The way the authors have analyzed their data it tells us this is a promising drug. Had they done an intention to treat analysis very likely the opposite would've been the result.
The only thing that trial tells us is that if you do a bad trial you're as clueless as before.
The way the authors have analyzed their data it tells us this is a promising drug. Had they done an intention to treat analysis very likely the opposite would've been the result.
The only thing that trial tells us is that if you do a bad trial you're as clueless as before.